13D Filing: Boyalife Investment Enters Into Agreement With Cesca Therapeutics Inc. (KOOL)

Page 44 of 67

Page 44 of 67 SEC Filing

IN WITNESS WHEREOF,
the Company has caused this instrument to be duly executed as of the date first set forth above.

COMPANY:
CESCA THERAPEUTICS INC.
By:
Robin Stracey
Chief Executive Officer
Address: 2711 Citrus Road
Rancho Cordova, California 95742

ACKNOWLEDGED AND AGREED:

PAYEE:

BOYALIFE INVESTMENT INC.

By:
Name:
Address:

(Signature Page to Secured Convertible
Debenture)

Follow Thermogenesis Holdings Inc. (NASDAQ:THMO)

Page 44 of 67